Home›Lidocaine Hydrochloride And Epinephrine Bitartrate›Lidocaine Hydrochloride And Epinephrine Bitartrate + Topical Local Anesthetics

Does Lidocaine Hydrochloride And Epinephrine Bitartrate Interact with Topical Local Anesthetics?

CDI records a major classification for Lidocaine Hydrochloride And Epinephrine Bitartrate and Topical Local Anesthetics. The stored summary is: Serious dose-related cardiac arrhythmias may occur when epinephrine-containing preparations are used during or following potent inhalation anesthetics. The mechanism involves cardiac sensitization to catecholamines. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Major
Lidocaine Hydrochloride And Epinephrine Bitartrate Class
alpha-Adrenergic Agonist
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

Cardiac sensitization to catecholamines

What To Tell Your Doctor or Pharmacist

If you are taking Lidocaine Hydrochloride And Epinephrine Bitartrate and your doctor is considering prescribing Topical Local Anesthetics (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Lidocaine Hydrochloride And Epinephrine Bitartrate(Lidocaine)+💊 Topical Local Anesthetics(Gelato Anesthetic)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
alpha-Adrenergic Agonist
Drug B class
—
Source
NLP:lidocaine hydrochloride and epinephrine

What this means in plain English

Serious dose-related cardiac arrhythmias may occur when epinephrine-containing preparations are used during or following potent inhalation anesthetics.

About Lidocaine Hydrochloride And Epinephrine Bitartrate and Topical Local Anesthetics

Lidocaine Hydrochloride And Epinephrine Bitartrate is an alpha-Adrenergic Agonist. Topical Local Anesthetics is also sold under the brand name Gelato Anesthetic.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:lidocaine hydrochloride and epinephrine

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Lidocaine Hydrochloride And Epinephrine Bitartrate and Topical Local Anesthetics against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations